The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeneca Growth Regulatory News (HYG)

Share Price Information for Seneca Growth (HYG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.50
Bid: 10.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 7.00 (70.00%)
Open: 13.50
High: 13.50
Low: 13.50
Prev. Close: 13.50
HYG Live PriceLast checked at -
Seneca Growth Capital VCT is an Investment Trust

To provide shareholders with an attractive income and capital return by investing its funds in a portfolio of both unquoted and quoted UK MedTech companies which meet the relevant criteria under the VCT Rules.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update for the quarter ended 30 September 2018

23 Nov 2018 07:00

RNS Number : 2789I
Seneca Growth Capital VCT PLC
23 November 2018
 

Seneca Growth Capital VCT Plc (the "Company")

Update for the quarter ended 30 September 2018

The Company presents its quarterly update for the period from 1 July 2018 to 30 September 2018.

The Directors have recently reviewed the valuation of its portfolio as at the quarter ended 30 September 2018.

The unaudited net asset value per share ("NAV") of an Ordinary Share as at 30 September 2018 was 60.4p. This is a decrease of 1.9p from the previously published NAV for the period ended 30 June 2018, due to changes in the value of the quoted investments. No changes have been made to the unquoted valuations. The ordinary running costs of the Company (limited by the Cost Cap) have been absorbed by the New "B" Share class as set out in the prospectus for the current offer for subscription for those shares (the "Prospectus").

The unaudited NAV of a New "B" Share as at 30 September 2018 was 99.7p. This is a decrease of 0.3p from the initial offer price of 100p, due to running costs incurred in the quarter. The decrease is limited by the impact of the Cost Cap which restricts the burden of ordinary running costs on the New "B" Share class to 3% of the NAV of the New "B" Shares on an annualised basis ("the Cost Cap").

On 23 August 2018 and 27 September 2018, the Company made two allotments, issuing a total of 3,461,786 New "B" Shares. In accordance with the allotment formula set out in the Prospectus, the offer prices at which the New "B" Shares were issued were in the range of 100p to 105.8p per share.

Following the initial allotment on 23 August 2018, the Company repaid its £200,000 bank loan with RBS and the debenture in relation to the loan has now been released. The payment created an inter share class balance between the Ordinary Shares and the New "B" Shares which will be repaid from the next realisations from the Ordinary Share investments.

James Cowper Kreston, our auditors for the last 8 years, have decided to withdraw from auditing Public Interest Entities for the time being due to the increasing regulatory landscape and associated costs. Unfortunately this includes VCTs. The Board would like to thank them for all their support and constructive feedback during their period in office. The Company has therefore carried out a tender process, and the Board, on the recommendation of the Audit Committee, has agreed to appoint UHY Hacker Young LLP ("UHY") to fill the casual vacancy that has arisen. UHY will audit the Company's 2018 annual results for the year ending 31 December 2018, and shareholders will be asked to reappoint them at next year's AGM for the following year's audit.

The Directors are not aware of any other events or transactions which have taken place between 1 October 2018 and the publication of this statement which have had a material effect on the financial position of the Company.

Furthermore, for the purposes of DTR 5.6.1 of the Financial Conduct Authority's (FCA) Disclosure Guidance and Transparency Rules, the total number of shares in the Company in issue as at close of business on 1 October 2018 was 8,115,376 Ordinary Shares and 3,461,786 New "B" Shares each with a nominal value of 1p each. The Company does not hold any Ordinary Shares nor New "B" Shares in treasury. Therefore, the total number of voting rights in the Company is 11,577,162 (the 'Figure').The Figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's shares under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please contact:

 

John Hustler, Seneca Growth Capital VCT Plc at john.hustler@btconnect.com

 

Richard Manley, Seneca Growth Capital VCT Plc at Richard.Manley@senecapartners.co.uk

 

Any enquiries regarding the offer for subscription of New "B" Shares should be directed to:

 

John Davies at Seneca Partners Limited on 01942 295 981 or at John.Davies@senecapartners.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDVLLFLVFFLFBB
Date   Source Headline
22nd Apr 202410:46 amGNWShare Buy-back and Total Voting Rights
5th Apr 202412:44 pmGNWIssue of Equity and Total Voting Rights
4th Apr 20247:00 amGNWNet Asset Value(s)
28th Mar 202412:11 pmGNWIssue of Supplementary Prospectus
22nd Mar 20247:00 amGNWFinal Results, Notice of AGM, Updated NAV
7th Mar 20247:00 amGNWInterim Dividend on B Shares
19th Feb 20244:36 pmGNWDirector Declaration
21st Dec 202312:03 pmGNWIssue of Equity and Total Voting Rights
6th Dec 20233:24 pmGNWDirector/PDMR Dealing
6th Dec 20233:14 pmGNWIssue of Equity and Total Voting Rights
29th Nov 202312:36 pmGNWChange of the Company’s Auditor
20th Nov 20233:20 pmGNWB Share Buy-back and Total Voting Rights
3rd Nov 20237:00 amGNWDividend Declaration
12th Oct 20237:00 amGNWNet Asset Value(s)
11th Oct 20233:39 pmGNWDirectorate Change
24th Aug 20234:18 pmGNWOffer for Subscription and Publication of Prospectus
18th Aug 20235:08 pmGNWIssue of Equity and Total Voting Rights and Capital Reorganisation
2nd Aug 202311:40 amGNWHalf-year Report
30th Jun 20231:58 pmGNWIssue of Equity and Total Voting Rights
20th Jun 20238:50 amGNWShare Buy-back and Total Voting Rights
18th May 20231:38 pmGNWDirectorate Changes
18th May 20231:32 pmGNWResults of Annual General Meeting Voting
3rd May 20234:01 pmGNWIssue of Equity and Total Voting Rights
27th Apr 202311:25 amGNWPublication of a Supplementary Prospectus
21st Apr 20237:00 amGNWFinal Results for the Year Ended 31 December 2022
5th Apr 20233:05 pmGNWIssue of Equity and Total Voting Rights
4th Apr 20237:00 amGNWNet Asset Value(s)
7th Mar 20231:30 pmGNWInterim Dividend Declarations
21st Dec 20227:00 amGNWB Share Portfolio Update
7th Dec 20227:00 amGNWOrdinary Share NAV Update and Dividend Declaration
30th Nov 202212:33 pmGNWDirector/PDMR Shareholding
30th Nov 202212:29 pmGNWIssue of Equity and Total Voting Rights
19th Oct 20227:00 amGNWSecond Interim Dividend on B Shares
13th Oct 20227:00 amGNWNAV Update
26th Aug 202211:56 amGNWOffer for Subscription and Publication of Prospectus
22nd Aug 20222:53 pmGNWPDMR Shareholding
22nd Aug 20222:46 pmGNWIssue of Equity and Total Voting Rights
16th Aug 20227:00 amGNWB Share Closure of Offer for Subscription
15th Jul 20227:00 amGNWHalf-year report
30th Jun 202210:17 amGNWIssue of Supplementary Prospectus
23rd May 20227:00 amGNWAppointment of Auditor
23rd May 20227:00 amGNWShare Buy-back and TVR
4th May 202211:25 amGNWIssue of Equity and Total Voting Rights
27th Apr 20223:42 pmGNWResult of AGM
5th Apr 20221:56 pmGNWIssue of Equity and Total Voting Rights
1st Apr 20221:43 pmGNWIssue of Equity and Total Voting Rights
1st Apr 202211:05 amGNWNAV Update
25th Mar 202210:00 amGNWIssue of Supplementary Prospectus
25th Mar 20227:01 amGNWNAV Update
25th Mar 20227:00 amGNWFinal Results for the Year Ended 31 December 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.